Phase 3 Study Results of Obicetrapib on Alzheimer Disease Biomarker Progression

In this video interview, Philip Scheltens, MD, PhD, Emeritus Professor of Cognitive Neurology at VU University Medical Center, talked about findings presented at AAIC 2025 from the phase 3 BROADWAY trial of obicetrapib in Alzheimer disease.

Click here to read more about the conversation 👉 https://www.neurologylive.com/view/ph...

Direct Access to Expert Insight in Neurology

NeurologyLive® is a trusted news source for breaking drug approvals, pipeline trials, and emerging trends in neurology for physicians and clinicians. Visit neurologylive.com for more!

The multimedia publication provides physicians and other healthcare professionals with up-to-date disease-specific news, clinical information, and other resources that can help them provide better care to patients. At NeurologyLive, you'll find in-depth conference coverage and information about upcoming meetings, content from our affiliated print journals, video interviews with leading physician experts, and other multimedia resources.

Get all the latest news on individual medical conditions in our condition centers:
• Dementia & Alzheimer Disease // https://www.neurologylive.com/clinica...
• Epilepsy // https://www.neurologylive.com/clinica...
• Headache & Migraine // https://www.neurologylive.com/clinica...
• Movement Disorders // https://www.neurologylive.com/clinica...
• Multiple Sclerosis // https://www.neurologylive.com/clinica...
• Neuromuscular // https://www.neurologylive.com/clinica...
• Sleep Medicine // https://www.neurologylive.com/clinica...
• Stroke // https://www.neurologylive.com/clinica...

We post new videos on YouTube every Monday, Wednesday, and Friday!

🧠Subscribe now to our channel ➜     / neurologylive  

📲 Follow us on our socials:
🔹 X: https://x.com/neurology_live
🔹LinkedIn:    / neurology-live  
🔹Facebook:   / neurologylive  

📧 Subscribe to our eNewletter ➜ https://one.neurologylive.com/subscribe/